Conference

Opening BvCW

• Jürgen Neumeyer

Is it worth growing hemp now? The need for an industrial hemp law

• Florian Pichlmaier

• Daniel Kruse

Why building with hemp has a future – Where are the hemp houses?

• Roger Dauer

• Gökcan Güney

• Marijn Roersch van de Hoogte

Keynote “Progress in medical cannabis – MedCanG and Co. – Where is the journey going?”

• Dr. Knut Gastmeier

Reservation of authorization – Are there other ways to improve access?

• Dr. Franjo Grotenhermen

• Armin Prasch

Medical cannabis cultivation in Germany – progress and need for improvement

• Dr. Adrian Fischer

• Dr. Niels Lutzhöft

• Dirk Heitepriem

• Dr. Christiane Neubaur

Keynote “Cannabis policy summit”

• Jürgen Neumeyer

Panel: After the law is before the law – CanG on its way, what’s next?

• Ates Gürpinar

• Carmen Wegge

• Kristine Lütke

• Kirsten Kappert-Gonther

Reduce competitive disadvantages: Why do we need an Industrial Hemp Act?

• Jürgen Neumeyer

• Karl Bär

Keynote “Commercial cannabis seed trade and advertising regulations in the context of their marketing”

• Dr. Ferdinand Weis

• Maren Wahler

Keynote “A foundation for a functioning legal cannabis economy”

• Lisa Haag

Panel “Blossoming of a new industry: The economy for cannabis cultivation clubs?”

• Stefan Röhrl

• Henry Wieker

• Nikolaos Katsaras

• Lisa Haag

Panel “Advertising & selling – current topics for the trade in legal hemp and cannabis products”

• Philipp Ferrer

• Dr. Ferdinand Weis

• Lisa Haag

• Sven Kalies

Cannabis & Culture

From seed to harvest in 100 days

• Vincent Kühne

Medizinisches Cannabis ist kein Gras! – Skurrile Blüten im neuen Cannabisgesetz

• Michael Knodt

Cannabis im Alltag, Arbeit, Führerschein, Arztbesuche, soziales Umfeld

• Gregor Cichy

• Alexander Daske

• Dr. aserb.med.univ. Akif Hidayatov

• Maximilian Plenert

Die wichtigsten Indikationen und die Wirkung von Medizinischem Cannabis

• Melanie Dolfen

Anbau und der Produktion von medizinischem Cannabis: Einblicke in die bewährten Methoden, Techniken und rechtlichen Aspekte

• Dr. Adrian Fischer

Bühnendiskussion über Medizinisches Cannabis in Apotheken (Ihr fragt, wir antworten)

• Patricia Christl

Understanding cannabis patients: Insight into the customer journey for targeted marketing

• Ebru Broda